213 related articles for article (PubMed ID: 24960520)
1. Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.
Wadelius M; Marshall SE; Islander G; Nordang L; Karawajczyk M; Yue QY; Terreehorst I; Baranova EV; Hugosson S; Sköldefors K; Pirmohamed M; Maitland-van der Zee AH; Alfirevic A; Hallberg P; Palmer CN
Clin Pharmacol Ther; 2014 Oct; 96(4):477-81. PubMed ID: 24960520
[TBL] [Abstract][Full Text] [Related]
2. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitor-induced angioedema: epidemiology, pathogenesis and management.
Sobotková M
Vnitr Lek; 2018; 64(10):928-933. PubMed ID: 30590939
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system blockers increase risk of angio-oedema.
Volpe M; Tocci G
Evid Based Med; 2013 Dec; 18(6):e52. PubMed ID: 23635842
[No Abstract] [Full Text] [Related]
5. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
6. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema.
Stone C; Brown NJ
Immunol Allergy Clin North Am; 2017 Aug; 37(3):483-495. PubMed ID: 28687104
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin Metabolism and Drug-Induced Angioedema.
Smolinska S; Antolín-Amérigo D; Popescu FD
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511409
[TBL] [Abstract][Full Text] [Related]
9. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
Chiu AG; Krowiak EJ; Deeb ZE
Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of medications in real-world practice:
Katz MH
Arch Intern Med; 2012 Nov; 172(20):1590. PubMed ID: 23070135
[No Abstract] [Full Text] [Related]
11. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
Hirschy R; Shah T; Davis T; Rech MA
Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic.
Rasmussen ER; Mey K; Bygum A
Acta Derm Venereol; 2014 May; 94(3):260-4. PubMed ID: 24285044
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
Warner KK; Visconti JA; Tschampel MM
Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
[TBL] [Abstract][Full Text] [Related]
15. Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.
Wilson M; Frohna W; Trent G; Sauter D
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):178-9. PubMed ID: 24468261
[No Abstract] [Full Text] [Related]
16. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].
Bas M; Kojda G; Stelter K
Anaesthesist; 2011 Dec; 60(12):1141-5. PubMed ID: 20922352
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
Byrd JB; Touzin K; Sile S; Gainer JV; Yu C; Nadeau J; Adam A; Brown NJ
Hypertension; 2008 Jan; 51(1):141-7. PubMed ID: 18025295
[TBL] [Abstract][Full Text] [Related]
19. [Drug induced angioedema (ACE-inhibitors and other)].
Fain O; Mekinian A; Gobert D; Khau CA; Javaud N
Presse Med; 2015 Jan; 44(1):43-7. PubMed ID: 25511647
[TBL] [Abstract][Full Text] [Related]
20. Angioedema: a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors.
Davin L; Marechal P; Lancellotti P; Martinez C; Pierard L; Radermecker R
Acta Cardiol; 2019 Aug; 74(4):277-281. PubMed ID: 30328786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
